MTOR and mitochondrial disease: Indeed, in a small clinical study, the mitochondrial disease phenotypes of four kidney transplant patients with mitochondrial disease (MELAS) improved after the immunosuppressant was replaced with rapamycin to achieve mTOR inhibition.37